Search results

Evidence-based recommendations on enzalutamide (Xtandi) for treating metastatic hormone-relapsed prostate cancer in adults who have had treatment with docetaxel-containing chemotherapy.

Result type

Technology appraisal guidance

Published

23 July 2014

Evidence-based recommendations on procalcitonin testing for diagnosing and monitoring sepsis (ADVIA Centaur BRAHMS PCT assay, BRAHMS PCT Sensitive Kryptor assay, Elecsys BRAHMS PCT assay, LIAISON BRAHMS PCT assay and VIDAS BRAHMS PCT assay)

Result type

Diagnostics guidance

Published

7 October 2015

NICE has developed a medtech innovation briefing (MIB) on Boston Keratoprosthesis Type I for corneal blindness .

Result type

Medtech innovation briefing

Published

18 January 2017

Evidence-based recommendations on ruxolitinib (Jakavi). This drug is for adults with disease-related splenomegaly or symptoms caused by primary myelofibrosis (also known as chronic idiopathic myelofibrosis), post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis, only if they have intermediate-2 or high-risk disease.

Result type

Technology appraisal guidance

Published

23 March 2016

This guideline has been updated and replaced by NICE guideline CG108.

Result type

Clinical guideline

Published

23 July 2003

Evidence-based recommendations on cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for treating intermittent claudication in adults with peripheral arterial disease.

Result type

Technology appraisal guidance

Published

25 May 2011

NICE has developed a medtech innovation briefing (MIB) on clonoSEQ for minimal residual disease assessment in multiple myeloma, acute lymphoblastic leukaemia and chronic lymphocytic leukaemia .

Result type

Medtech innovation briefing

Published

30 November 2021

Evidence-based recommendations on erenumab (Aimovig) for preventing migraine in adults.

Result type

Technology appraisal guidance

Published

10 March 2021

the combination of both in children and young people in the care system and on the edge of care.Investigate the effect of...

Result type

Research recommendation

Published

11 December 2015

Evidence-based recommendations on lorlatinib (Lorviqua) for previously treated ALK-positive advanced non-small-cell lung cancer in adults.

Result type

Technology appraisal guidance

Published

13 May 2020

NICE has developed a medtech innovation briefing (MIB) on TUC Safety Valve to prevent balloon inflation in the urethra during transurethral catheterisation .

Result type

Medtech innovation briefing

Published

17 March 2020

Evidence-based recommendations on deep brain stimulation for tremor and dystonia (excluding Parkinson's disease). This involves planting electrodes in the brain and generating electrical currents to help control the tremor or dystonia.

Result type

Interventional procedures guidance

Published

23 August 2006

NICE has developed a medtech innovation briefing (MIB) on the Shiley Endotracheal Tube with TaperGuard Cuff .

Result type

Medtech innovation briefing

Published

2 March 2015

Evidence-based recommendations on mannitol dry powder for inhalation (Bronchitol) for treating cystic fibrosis in adults

Result type

Technology appraisal guidance

Published

28 November 2012

Evidence-based recommendations on guselkumab (Tremfya) for active psoriatic arthritis after inadequate response to DMARDs in adults.

Result type

Technology appraisal guidance

Published

10 August 2022